Chemical Week :: Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients http://www.chemweek.com Chemical Week en-us 2008 Tue, 7 Oct 2008 16:09:36 EDT ISP Among First to Obtain Pharmacopeia Seal Specialty and performance chemicals firm International Specialty Products (ISP; Wayne, NJ) says several of its products used in pharmaceutical manufacturing have been given the ‘verified... http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/14626.html Mon, 6 Oct 2008 0:00:00 EDT EFCG Welcomes Action on APIs The European Fine Chemicals Group (EFCG) told journalists at the CPhI expo in Frankfurt last week that enforcement against manufacturers of counterfeit medicines is “becoming much more... http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/14628.html Mon, 6 Oct 2008 0:00:00 EDT CPhI: Dow Brings Synthetic Glycerine Business Back Under its Domain Dow told CW at the recent CPhI expo in Frankfurt that since August, it has brought back its Optim synthetic glycerine business to the main Dow Chemical group, after a period of about three... http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/14649.html Mon, 6 Oct 2008 0:00:00 EDT Arsenal to Acquire Ferro’s Fine Chemicals Business Private equity firm Arsenal Capital Partners (New York) says it has signed a definitive agreement to acquire Ferro’s fine chemicals business, a leading producer of electrolytes used in manufacturing lithium ion batteries, for $66 million.... http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/14575.html Fri, 3 Oct 2008 0:00:00 EDT DSM to Close Clavulanic Acid Site  in Sweden DSM’s Anti-Infectives business says it will close a clavulanic acid production site at Strängnäs, Sweden. The site mainly produces clavulanic acid, which is used in the... http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/14562.html Thu, 2 Oct 2008 0:00:00 EDT Ranbaxy Hires Former NYC Mayor to Tackle FDA Import Restrictions India’s largest pharmaceutical company Ranbaxy Laboratories (Gurgaon, India) says it has hired former New York City mayor Rudy Giuliani and his consulting firm Giuliani Partners (New York)... http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/14495.html Mon, 29 Sep 2008 0:00:00 EDT Diapharm Offers Shared Third-Party Audits Pharmaceutical services provider Diapharm (Münster, Germany) says it has begun to offer accredited shared third-party audits for active pharmaceutical ingredients (APIs). The shared audit... http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/14334.html Mon, 22 Sep 2008 0:00:00 EDT Indian Contract Manufacture Market to Grow The Indian pharmaceutical contract manufacturing market, which was estimated at $869 million in 2007, is expected to grow to $2.46 billion by 2010, says a recent report by KPMG India... http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/14335.html Mon, 22 Sep 2008 0:00:00 EDT FDA Places Import Alert on Products from Two Ranbaxy Plants  U.S. FDA says it has issued an import alert for officials to detain drugs reaching the U.S. border that have been made at two Indian plants owned by pharmaceutical manufacturer Ranbaxy... http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/14281.html Thu, 18 Sep 2008 0:00:00 EDT Slower Growth for Chinese APIs The active pharmaceutical ingredients (API) sector in China will undergo slower growth this quarter, compared with the previous two quarters, according to speakers at the China International... http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/14200.html Mon, 15 Sep 2008 0:00:00 EDT